Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Change in Cash (2016 - 2025)

Historic Change in Cash for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to -$357407.0.

  • China Pharma Holdings' Change in Cash fell 163111.98% to -$357407.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$451066.0, marking a year-over-year increase of 3073.1%. This contributed to the annual value of -$796959.0 for FY2024, which is 3148.25% down from last year.
  • Latest data reveals that China Pharma Holdings reported Change in Cash of -$357407.0 as of Q3 2025, which was down 163111.98% from $212344.0 recorded in Q2 2025.
  • In the past 5 years, China Pharma Holdings' Change in Cash ranged from a high of $4.4 million in Q4 2021 and a low of -$1.5 million during Q2 2022
  • Over the past 5 years, China Pharma Holdings' median Change in Cash value was -$158664.0 (recorded in 2022), while the average stood at -$36317.3.
  • As far as peak fluctuations go, China Pharma Holdings' Change in Cash skyrocketed by 62011.87% in 2021, and later plummeted by 163111.98% in 2025.
  • China Pharma Holdings' Change in Cash (Quarter) stood at $4.4 million in 2021, then plummeted by 101.28% to -$56327.0 in 2022, then skyrocketed by 195.81% to $53967.0 in 2023, then crashed by 270.13% to -$91812.0 in 2024, then tumbled by 289.28% to -$357407.0 in 2025.
  • Its Change in Cash stands at -$357407.0 for Q3 2025, versus $212344.0 for Q2 2025 and -$214191.0 for Q1 2025.